论文信息 - 104PEfficacy of ceritinib in a "real-world" population of crizotinib-refractory ALK-positive NSCLCs: Results of the Italian compassionate use program - 字舞流文

104PEfficacy of ceritinib in a "real-world" population of crizotinib-refractory ALK-positive NSCLCs: Results of the Italian compassionate use program

R. Chiari | L. Bonanno | R. Giusti | V. Gregorc | G. Metro | A. Passaro | F. Cecere | E. Capelletto | O. Martelli | G. Russo